Results

1–10 of 12 results for randomized clinical trial

Expert Panel: Faricimab and Aflibercept 8 mg in AMD
John T. Thompson, MD
Andrew A. Moshfeghi, MD, MBA, FASRS
Manjot K Gill, MD, FASRS
Christina Y Weng, MD, MBA, FASRS
Ferhina S Ali, MD, MPH
Ian Pearce, MB ChB BSc FRCOPHTH
Annual Meeting Talks
2024
Silicone Oil Droplets in the Vitreous After Intravitreal Injection With a Silicone Oil-Free and a Siliconized Insulin Syringe: A Randomized Clinical Trial
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2024
Baseline Factors Associated With 1-Year Outcomes in Phase III Comparison of SB11 (Approved Ranibizumab Biosimilar) With Reference Ranibizumab in nAMD
Neil M. Bressler, MD
Annual Meeting Talks
2022
High-Speed Beveled Tip vs Standard Tip Vitrectomy Probe: Prospective Randomized Clinical Trial
On Demand Cases, Courses, and Papers
2022
A Randomized Clinical Trial of Pneumatic Vitreolysis for Vitreomacular Traction: DRCR Retina Network Protocol AG
Clement K. Chan, MD, FACS
Annual Meeting Talks
2021
A Phase 2 Safety and Efficacy Trial of AU-011, a Virus-Like Drug Conjugate, With Dose Escalation and Randomized Masked Expansion in Uveal Melanoma
Prithvi Mruthyunjaya, MD, MHS
Annual Meeting Talks
2021
Effect of Adjuvant Topical Dorzolamide-Timolol Versus Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
Jason Hsu, MD
On Demand Cases, Courses, and Papers
2020
Canadian Treat-and-Extend Trial With Ranibizumab in nAMD Patients: CANTREAT 36-Month Extension Results
Peter J. Kertes, MD, FRCS(C)
Annual Meeting Talks
2020
A Phase 2 Safety and Efficacy Trial of AU-011, a Virus-Like Drug Conjugate, With Dose Escalation and Randomized Masked Expansion in Uveal Melanoma
Prithvi Mruthyunjaya, MD, MHS
Updates from the Field
2021
A Randomized Clinical Trial of Pneumatic Vitreolysis for Vitreomacular Traction: DRCR Retina Network Protocol AG
Clement K. Chan, MD, FACS
Updates from the Field
2021